Denosumab is indicated for treating osteoporosis in postmenopausal women, preventing skeletal-related complications in cancer ...
Pharmaceutical Technology on MSN
Regeneron’s Evkeeza gains FDA approval for young HoFH patients
The decision to broaden the antibody’s indication was based on clinical efficacy and safety data from six children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback